help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2008.071218 on October 2, 2008

Published online before print October 2, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2008.071218v1
173/5/1428    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toledo, C. C.
Right arrow Articles by Karpman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toledo, C. C.
Right arrow Articles by Karpman, D.
(American Journal of Pathology. 2008;173:1428-1439.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.071218

Shiga Toxin-Mediated Disease in MyD88-Deficient Mice Infected with Escherichia coli O157:H7

Carla Calderon Toledo*, Trisha Jayne Rogers*{dagger}, Majlis Svensson{dagger}, Ramesh Tati*, Hans Fischer{dagger}, Catharina Svanborg{dagger} and Diana Karpman*

From the Department of Pediatrics,* Clinical Sciences Lund, Lund University; and Department of Microbiology, Immunology and Glycobiology,{dagger} Institute of Laboratory Medicine, Lund University

Toll-like receptors (TLRs) are key factors of innate immunity that detect pathogen invasion and trigger a host response. TLR4 can mediate a response through adaptor molecules, MyD88 or TRIF. In the present study, streptomycin-treated MyD88–/–, Tlr4–/–, Trif Lps2/Lps2, and C57BL/6 wild-type (WT) mice were infected with either Shiga toxin (Stx)-producing or non-producing Escherichia coli O157:H7. Moderate to severe clinical signs of disease developed in MyD88–/– (n = 21/21), Tlr4–/– (n = 12/16), Trif Lps2/Lps2 (n = 7/15) and WT mice (n = 6/20) infected with Stx-producing E. coli O157:H7 but not in mice inoculated with the Stx non-producing strain (n = 0/54, P < 0.001). MyD88–/– mice infected with Stx-producing E. coli O157:H7 developed the most severe disease and had the highest bacterial burden. Hematological analysis of sick MyD88–/– mice showed reduced red blood cell counts and reticulocytosis, suggesting hemolysis. Thrombocytopenia developed in MyD88–/–, Trif Lps2/Lps2, and WT mice, and creatinine levels were elevated in both MyD88–/– and WT mice infected with the Stx-producing strain. Renal histopathology showed evidence of glomerular capillary congestion, tubular desquamation, and fibrinogen deposition, and intestinal histopathology showed mucosal injury, edema, and inflammation in sick mice. Administration of purified Stx2 to MyD88–/– and WT mice led to severe disease in both groups, suggesting that MyD88–/– mice are not more sensitive to Stx than WT mice. As MyD88–/– mice developed the most severe disease hematological and pathological changes, the results suggest that dysfunctional innate immune responses via MyD88 enhanced Stx-induced disease.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.